News & Events
February 27, 2018
Patient-Reported Outcome (PRO) Consortium Translation Process: Consensus Development of Updated Best Practices
Eremenco S, Pease S, Mann S, Berry P, on behalf of the PRO Consortium’s Process Subcommittee. Patient-Reported Outcome (PRO) Consortium translation process: consensus development of updated best practices. Journal of Patient-Reported Outcomes. 2017;(2):12.
January 22, 2018
Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort
Church RJ, Kullak-Ublick GA, Aubrecht J, Bonkovsky HL, Chalasani N, Fontana RJ, et al. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology. 2018 Jan 22.
January 1, 2018
Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs
Gu, Yi-Zhong, Katerina Vlasakova, Sean P. Troth, Robert L. Peiffer, Herve Tournade, Flavia R. Pasello Dos Santos, Warren E. Glaab, and Frank D. Sistare. “Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-Induced Renal Tubular Injury in Tenofovir-Treated Cynomolgus Monkeys and Beagle Dogs.” Toxicologic Pathology, January 1, 2018, 192623318775023..
January 1, 2018
Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition
Cepa, Steven, David Potter, Lisa Wong, Leah Schutt, Jacqueline Tarrant, Jodie Pang, Xiaolin Zhang, et al. “Individual Serum Bile Acid Profiling in Rats Aids in Human Risk Assessment of Drug-Induced Liver Injury Due to BSEP Inhibition.” Toxicology and Applied Pharmacology 338 (01 2018): 204–13.
- January 1, 2018